Clay Thorp Insider Trading for October 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Clay Thorp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of Clay Thorp for October 2018.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Thorp Clay | Director | Option Exercise | C | 0.00 | 226,061 | 0 | 0 | |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Thorp Clay | Director | Option Exercise | C | 0.00 | 24,709 | 0 | 0 | |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Thorp Clay | Director | Option Exercise | C | 0.00 | 272,107 | 0 | 0 | |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Thorp Clay | Director | Option Exercise | C | 0.00 | 40,420 | 0 | 0 | |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Thorp Clay | Director | Option Exercise | C | 0.00 | 13,558 | 0 | 0 | |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Thorp Clay | Director | Option Exercise | C | 0.00 | 149,320 | 0 | 0 | |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Thorp Clay | Director | Option Exercise | C | 0.00 | 94,874 | 0 | 0 | |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Thorp Clay | Director | Option Exercise | C | 0.00 | 1,044,764 | 0 | 0 | |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Thorp Clay | Director | Option Exercise | C | 0.00 | 13,609 | 0 | 0 | |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Thorp Clay | Director | Option Exercise | C | 0.00 | 174,699 | 0 | 0 | |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Thorp Clay | Director | Option Exercise | C | 0.00 | 4,846 | 0 | 0 | |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Thorp Clay | Director | Option Exercise | C | 0.00 | 3,862 | 0 | 0 | |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Thorp Clay | Director | Option Exercise | C | 0.00 | 42,530 | 0 | 0 | |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Thorp Clay | Director | Option Exercise | C | 0.00 | 52,690 | 0 | 0 | |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Thorp Clay | Director | Option Exercise | S | 0.00 | 994 | 0 | 40,420 | |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Thorp Clay | Director | Option Exercise | M | 0.00 | 41,414 | 0 | 41,414 | |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Thorp Clay | Director | Option Exercise | M | 0.12 | 41,414 | 4,970 | 0 | |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Thorp Clay | Director | Option Exercise | S | 0.00 | 104 | 0 | 13,558 | |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Thorp Clay | Director | Option Exercise | M | 0.00 | 4,309 | 0 | 13,662 | |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Thorp Clay | Director | Option Exercise | M | 0.12 | 4,309 | 517 | 0 | |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Thorp Clay | Director | Option Exercise | S | 0.00 | 1,139 | 0 | 149,320 | |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Thorp Clay | Director | Option Exercise | M | 0.00 | 47,458 | 0 | 150,459 | |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Thorp Clay | Director | Option Exercise | M | 0.12 | 47,458 | 5,695 | 0 | |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Thorp Clay | Director | Option Exercise | S | 0.00 | 42 | 0 | 94,874 | |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Thorp Clay | Director | Option Exercise | M | 0.00 | 1,731 | 0 | 94,916 | |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Thorp Clay | Director | Option Exercise | M | 0.12 | 1,731 | 208 | 0 | |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Thorp Clay | Director | Option Exercise | S | 0.00 | 458 | 0 | 1,044,764 | |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Thorp Clay | Director | Option Exercise | M | 0.00 | 19,061 | 0 | 1,045,222 | |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Thorp Clay | Director | Option Exercise | M | 0.12 | 19,061 | 2,287 | 0 | |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Thorp Clay | Director | Buy | P | 5.00 | 150,000 | 750,000 | 416,481 | 266.5 K to 416.5 K (+56.29 %) |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Thorp Clay | Director | Buy | C | 0.00 | 266,481 | 0 | 266,481 | 0 to 266.5 K |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Thorp Clay | Director | Buy | C | 0.00 | 4,846 | 0 | 4,846 | 0 to 4.8 K |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Thorp Clay | Director | Buy | P | 5.00 | 12,487 | 62,435 | 163,099 | 150.6 K to 163.1 K (+8.29 %) |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Thorp Clay | Director | Buy | C | 0.00 | 150,612 | 0 | 150,612 | 0 to 150.6 K |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Thorp Clay | Director | Buy | P | 5.00 | 137,513 | 687,565 | 1,820,933 | 1.7 M to 1.8 M (+8.17 %) |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Thorp Clay | Director | Buy | C | 0.00 | 1,683,420 | 0 | 1,683,420 | 0 to 1.7 M |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Thorp Clay | Director | Buy | C | 0.00 | 52,690 | 0 | 52,690 | 0 to 52.7 K |